Although this treatment is specific to a single-target antigen and quite effective for B cell lymphomas that commonly express CD19 [7], applying this method to treat other types of cancers is challenging because of variations of cancer antigens among different cancer types and individual patients. The gene discussed is CD19; the disease is cancer.